Merck KGaA : Positive outlook – phasing towards H2
>Strong underlying demand in Life Sciences - In the last quarter, Life sciences posted revenues of € 2,606m with organic growth of 4.2%. The strongest divisional driver was Process solutions with 10% organic growth. We acknowledge that the underlying growth in the most important division was even 24% (core business excl. Covid-related revenues), which we regard as clearly positive. We acknowledge that the order intake was up sequentially compared to Q3 driven by the ...Merck is a global science and technology company based in Germany. Co. diversifies its activities into four business divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. The Merck Serono develops, manufactures and markets prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, and selected cardiovascular and metabolic diseases. The Consumer Health manufactures and markets over-the-counter drugs addressing health themes such as mobility, women's and children's health, cough and cold. Performance Materials is a specialty chemicals business. The Merck Millipore is the supplier of products and services for the life science industry.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.